Avanza Fonder
ABBV icon

Avanza Fonder’s AbbVie ABBV Stock Holding History

Avanza Fonder’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$871K Hold
3,329
– – 0.02% 347
2026
Q2 		$838K Hold
3,329
– – 0.02% 352
2026
Q1 		$724K Sell
3,329
-6,886
-67% -$1.53M 0.02% 364
2025
Q4 		$2.33M Buy
10,215
+3,834
+60% +$873K 0.06% 249
2025
Q3 		$1.48M Buy
6,381
+338
+6% +$68.8K 0.04% 303
2025
Q2 		$1.12M Sell
6,043
-782
-11% -$145K 0.03% 328
2025
Q1 		$1.4M Sell
6,825
-1,618
-19% -$315K 0.05% 304
2024
Q4 		$1.5M Buy
+8,443
New +$1.55M 0.04% 298

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Avanza Fonder's ABBV Position: Q3 2026 in Review

Avanza Fonder held its AbbVie (ABBV) position steady in Q3 2026 at 3,329 shares worth $871K. The position accounts for 0.02% of the portfolio, ranked #347.

Avanza Fonder first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.33M in Q4 2025. 3,301 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Avanza Fonder held 3,329 shares of AbbVie worth $871K as of Q3 2026.
  • Avanza Fonder left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.02% of Avanza Fonder's portfolio in Q3 2026, its #347 holding.
  • Avanza Fonder first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • Avanza Fonder's AbbVie position peaked at $2.33M in Q4 2025.
  • 3,301 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Avanza Fonder's 13F filing for Q3 2026, filed 13 Oct 2026.